Equity Research firms currently have a positive stance on shares of GW Pharmaceuticals plc (NASDAQ:GWPH). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.10. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $138.13 on a short term basis.
At the time of writing, the stock was trading at $133.12. This represents a change from the opening price of -0.76%. In terms of performance, year to date, the stock is 91.07%. The monthly stock performance comes in at 61.25%. For the quarter, shares are performing at 43.90%. Weekly performance analysis shows the equity at 5.25%.
In taking a look at technical levels, shares are trading 37.21% away from the 50 day simple moving average and 69.98% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -1.51% away from it’s 52- week high and 271.53% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, GW Pharmaceuticals plc’s RSI stands at 80.16. In looking at volatility levels, the shares saw weekly volatility of 4.22% and 5.46% over the past month.